Drug banned in Guernsey amid fears it's not fit for consumption

Guernsey's health department is urging all users or former users of a controversial cancer drug GcMAF to contact their GP.

The unlicenced drug has been banned after its UK factory closed amid fears materials used aren't fit for human consumption.

Hundreds of islanders have already pleaded with politicians and health officials to have the ban lifted.

View all 25 updates ›

HSSD to consider alternatives to GcMAF


Guernsey's Health Department has revealed it will consider recommending the licensing of alternative regulated sources of GcMAF.

GcMAF is a drug which Guernsey resident David Noakes claims treats conditions like cancer, HIV and autism. Mr Noakes owns a Guernsey company which makes the unlicensed drug. However two weeks ago his factory closed amid fears materials used aren't fit for human consumption.

Today, island health bosses have been told by the UK regulator, MHRA, that there are no alternative sources of GcMAF.

However, the medicines regulator, Chief Pharmacist, Ed Freestone, says he would be prepared to consider recommending the licensing of a product if it went through the necessary approvals and controls.

I appreciate that patients using GcMAF for their personal treatment will want to try to obtain the product and this has been taken into consideration.

The restriction on GcMAF does not relate to any views about the company involved or the efficacy or otherwise of the product.

The decision to restrict imports of GcMAF was based on the urgent need to prevent the product which was being manufactured in a substandard way from posing any further risk to public health in Guernsey. It is for the manufacturers of GcMAF to provide assurance that the medicine is manufactured in accordance with the required standards. We remain ready, with the MHRA, to advise how to go about this process.

– Mr Freestone, Chief Pharmacist

Guernsey's Health Department are asking anyone who wishes to import GcMAF, should make contact with the Chief Pharmacist to discuss their proposed importation, from an alternative source.

More top news